Cyfuse Biomedical K.K.

Cyfuse Biomedical K.K.Cyfuse Biomedical K.K.

ABOUT

ABOUT

ABOUT

Company

Company Overview

Company name Cyfuse Biomedical K.K. (Japanese corporation)
CEO Shizuka Akieda
Founded August 11, 2010
Address South Tower-1F. Sumitomo Fudosan Tokyo Mita, 3-5-27, Mita, Minato-ku, Tokyo, 108-6301, JAPAN
Capital JPY 100,000,000 （as of the end of December 2020）
Businesses Development, manufacturing, and sales of regenerative medicine related products.

History

2010
  • August
    Founding of Cyfuse Biomedical K.K.
  • September
    Selected as an implementing agency, together with Kyushu University, of commissioned translational research in osteochondral regeneration, from NEDO.
2012
  • December
    Started selling the Bio 3D printer Regenova®.
2013
  • April
    Relocation of headquarters to the University of Tokyo Entrepreneur Plaza and opening of the Tokyo laboratory.
  • May
    Closed series A fundraising with JPY540 million.
2015
  • February
    Closed Series B fundraising with JPY1.4 billion.
  • September
    Started distribution of Regenova in the North America.
2018
  • August
    Closed Series C fundraising with JPY1.5 billion.
2019
  • January
    Started selling the Bio 3D printer S-PIKE®.

AWARDS

  • J-StartupJ-Startup
  • Japan Venture Awards 2019Japan Venture Awards 2019
NEXT：Introduction

ABOUT